Drug-resistant epilepsy in an autosomal recessive copper metabolism disorder from SLC33A1 mutation
Epilepsy & Behavior Reports · 2026-12 · 36 · 100894
DOI: 10.1016/j.ebr.2026.100894 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsy & Behavior Reports, 2026-12. Verfasst von Raunak Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, United States of America. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
SLC33A1 mutation (Huppke-Brendel Syndrome) is a rare, autosomal recessive disorder associated with copper metabolism and characterized by global developmental delay, sensorineural hearing loss, congenital cataract and generalized hypotonia. We report two siblings under 6 years with novel SLC33A1 gene mutation, born from heterozygous parents. The first patient developed early onset drug-resistant epilepsy (DRE) secondary to the novel genetic mutation; the second patient did not develop seizures but shared several other phenotypic features of the syndrome, highlighting intrafamilial variation in seizure penetrance. On electroencephalography of the first patient with DRE, independent spike and wave discharges were noted in the temporoparietal region with generalized background slowing. Diffuse electrodecrement with overriding paroxysmal fast activity was correlated with seizure semiology. Neuroimaging revealed generalized cerebral and cerebellar atrophy, ex-vacuo ventriculomegaly, and bilateral chronic subdural collections. We describe a shared genetic mutation in two siblings and highlight their overlapping and distinct clinical features, management challenges, and complications with invasive neuromodulation. These cases expand the differential diagnosis of copper-related metabolic disorders. Practical implications: Variable seizure penetrance in SLC33A1 related disorders could manifest as epileptic phenotypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN, United States of America.
Zitieren
APA
Singh, R., Kuo, C. Y., Sharma, S., Lundstrom, B. N., & Starnes, D. K. (2026). Drug-resistant epilepsy in an autosomal recessive copper metabolism disorder from SLC33A1 mutation. Epilepsy & Behavior Reports, 36, 100894. https://doi.org/10.1016/j.ebr.2026.100894
Vancouver
Singh R, Kuo CY, Sharma S, Lundstrom BN, Starnes DK. Drug-resistant epilepsy in an autosomal recessive copper metabolism disorder from SLC33A1 mutation. Epilepsy & Behavior Reports. 2026;36:100894. doi:10.1016/j.ebr.2026.100894
BibTeX
@article{Singh2026,
author = {Singh, Raunak and Kuo, Cheng Yen and Sharma, Shelja and Lundstrom, Brian Nils and Starnes, Donnie Keith},
title = {Drug-resistant epilepsy in an autosomal recessive copper metabolism disorder from SLC33A1 mutation},
journal = {Epilepsy & Behavior Reports},
year = {2026},
volume = {36},
pages = {100894},
doi = {10.1016/j.ebr.2026.100894}
}
EUVIMED